Baxter International Faces Class Action Lawsuit Over Alleged Securities Fraud

A class action lawsuit has been filed against Baxter International Inc. on behalf of investors who suffered losses due to alleged securities fraud between February 23, 2022, and July 30, 2025. The complaint alleges that Baxter made false statements and concealed critical information regarding its Novum LVP product, which reportedly suffered from systemic defects leading to malfunctions such as underinfusion, overinfusion, and complete non-delivery of fluids. These issues allegedly exposed patients to risks of serious injury or death. The lawsuit further claims that Baxter was aware of multiple device malfunctions, injuries, and deaths, and that their efforts to address the defects were inadequate, with design flaws persisting and continuing to cause harm. As a result, there was an increased risk that customers would be advised to take Novum LVPs out of service and that Baxter would halt new sales of the pumps. The legal action seeks to hold Baxter accountable for allegedly misleading statements about the safety, efficacy, and sales prospects of the Novum LVPs. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baxter International Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1114625) on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)